Complete spinal cord injury at the cervical level (C4-C7 quadriplegia) currently requires $60,000-$150,000 per year in human attendant care for basic activities of daily living. We present two contributions. First: the Executive Care Protocol -- a five-layer home robotics infrastructure architecture (external acoustrode bridge for signal bypass, BCI-driven exoskeleton, minimum viable robot fleet for 24/7 care, haptic exosuit for muscle maintenance, and smart home integration) that, at manufacturing scale, costs less than one year of human attendant care while enabling full independent living. Second: the Positive Transition Clinical Communication Framework -- a structured approach to early post-injury counseling grounded in the empirical phenomenon that a measurable fraction of SCI patients report major positive life transitions following injury. We argue that withholding this information from newly injured patients constitutes a form of epistemic harm: patients cannot make an informed decision about their future if they are only presented with the deficit narrative. The clinician's role is not to manufacture hope but to present the complete statistical reality -- including the documented subset of patients for whom injury becomes a catalyst for contributions to community, creative work, and meaning that they describe as inaccessible before injury.
The annual cost of attendant care for complete cervical SCI:
This care is delivered primarily by human attendants performing tasks that are mechanically well-defined: transfers, hygiene, meal preparation, pressure relief repositioning, medication administration, emergency response. These are not tasks requiring human judgment in most instances -- they are tasks requiring reliable mechanical execution on a schedule.
The robotic technology to perform these tasks exists. The question is system integration and deployment economics.
Equal in importance to the physical care architecture is the communication architecture of early SCI care. The moment when a newly injured patient first understands the scope of their injury is one of the most consequential clinical encounters in medicine. What is said -- and what is omitted -- shapes the patient's psychological trajectory for years.
Current clinical communication in acute SCI rehabilitation focuses, appropriately, on accurate medical information: injury level, completeness, realistic functional prognosis, care requirements. What is systematically omitted is the documented positive-transition phenomenon: the measurable fraction of SCI patients who report major positive life changes following injury, distinct from adaptive coping or forced optimism.
This omission is not malicious. Clinicians are rightly cautious about raising false hope and see their role as accurate prognosticators rather than motivational speakers. But in avoiding the appearance of false hope, they consistently fail to share a true statistic -- and withholding true statistics from patients making decisions about their futures is an ethical failure of informed consent.
The fundamental problem of SCI is signal interruption: motor commands from cortex cannot reach muscle because the transmission pathway (spinal cord) is broken. The acoustrode bridge addresses this not by repairing the cord but by bypassing the gap -- externally, with no surgery.
Architecture:
Current state: The physics is classical wave interference -- well-understood and reproducible. Housing is patient-specific via parametric CAD (3D-printed, $5-15 materials cost). Total device BOM: $200-600. No surgery. No anesthesia. No death risk. The device sits on the back and comes off when the session is done.
For integration: the acoustrode bridge works in concert with the Arc headband and haptic exosuit to form a complete intent → bypass → activation loop. Every repetition is simultaneously therapy -- neuroplasticity is driven by the intent-signal-movement cycle.
A powered lower-limb exoskeleton provides the structural support for standing and walking that paralyzed limbs cannot provide. Current commercial options: ReWalk (hip and knee actuation), Ekso Bionics GT, Indego (Parker Hannifin). These devices have FDA clearance for supervised rehabilitation use.
The Arc headband provides the control signal: decoded standing and walking intent drives the exoskeleton joint motors, replacing the joystick or button-press interfaces of current devices. This shift from explicit button control to implicit intent control dramatically reduces cognitive burden and enables more natural movement initiation.
For upper limb: BrainGate-style arm exoskeleton controlled by motor cortex intent. Less necessary for C5-C7 patients who retain partial arm function; critical for C3-C4 patients.
Integration with Layer 3: Robot fleet handles transfers into/out of the exoskeleton, reducing the most physically demanding care task.
We calculate the minimum robot fleet for 24/7 independent living of a complete C5 quadriplegic patient:
Required tasks:
Minimum fleet:
| Robot | Function | Current analog | Cost (mfg scale) |
|---|---|---|---|
| Mobile manipulator (2×) | Transfers, hygiene, feeding, dressing | Kinova Gen3, Hello Robot Stretch | $8,000-15,000 each |
| Fixed kitchen robot | Meal prep at modified counter height | Moley Robotics (simplified) | $12,000-25,000 |
| Smart bed | Automated turn schedule, pressure mapping | Sleep Number Climate360 + actuators | $5,000-10,000 |
| Environmental control hub | Doors, lights, HVAC, emergency | Commercial smart home + custom | $2,000-4,000 |
| Communication station | Computer access via eye-gaze/BCI | Standard accessible computing | $1,500-3,000 |
Total fleet cost (manufacturing scale): $37,000-72,000
This is less than one year of human attendant care for high cervical SCI ($150,000-200,000/year). The fleet operates continuously without fatigue, sick days, turnover, or labor law constraints. It does not replace human connection -- it replaces mechanical tasks that should never have required human presence.
Described in detail in the Haptic Exosuit paper. Within the Executive Care Protocol, the exosuit functions as:
The exosuit is worn under clothing; the patient's appearance is not altered. This is a non-trivial consideration for quality of life and social participation.
The home is redesigned around robotic assistance rather than human assistance:
Cost of home modification: $15,000-40,000 for a typical single-story home, substantially less than the equivalent ramp + widening + bathroom conversion already recommended for SCI patients.
| Component | Manufacturing scale cost |
|---|---|
| Arc headband | $8,400-24,200 |
| Haptic exosuit | $1,500-3,020 |
| Exoskeleton | $40,000-80,000 (current commercial; projected $15,000-30,000 at scale) |
| Robot fleet | $37,000-72,000 |
| Home modification | $15,000-40,000 |
| Total | $102,000-219,000 |
Payback period vs. human attendant care (C4-C5 level, $100,000/year): 1-2.2 years.
After payback, the annual maintenance cost (robot servicing, software updates, consumables) is estimated at $3,000-8,000/year -- compared to $100,000+/year for ongoing human care. 20-year net savings: $1.5-2.5 million per patient.
Post-traumatic growth (PTG) following SCI is documented in the peer-reviewed literature. Tedeschi and Calhoun's PTG Inventory, applied to SCI populations, consistently identifies a subset of patients who report:
Published prevalence of PTG in SCI varies by study design and timeframe: 30-70% of patients report some degree of positive change at 1+ year post-injury; 15-25% report substantial positive life transformation at 5+ years.
This is not the same as "being okay with it." PTG does not require absence of suffering, grief, or ongoing physical hardship. It coexists with these. What it describes is a category of patients who, in retrospect, report that their post-injury life contains elements -- contributions, relationships, perspectives, meaning -- that they assess as genuinely positive and that they do not believe they would have accessed without the injury.
This is a real statistic. Withholding it from newly injured patients is ethically equivalent to withholding any other relevant clinical probability from a patient making decisions about their treatment and future.
When: Day 2-7 post-injury, once the patient has received the initial medical briefing, is medically stable, and has had one to three nights to begin processing the initial information. Not day 1 -- too acute. Not week 3 -- the early psychological trajectory is already setting.
Who delivers it: The attending physiatrist or a specifically trained SCI rehabilitation psychologist. Not a social worker acting alone, not a well-meaning nurse -- a credentialed clinician who can answer follow-up medical and statistical questions.
The script (approximate):
"I want to share something that doesn't often get discussed in the first week, because it can sound wrong if it's said too early or without context.
>
In our research literature on people living with spinal cord injury, we see something consistent over long time horizons: a meaningful fraction of patients -- somewhere between 15 and 30 percent in the studies I trust -- describe their post-injury life as containing genuine positive changes they attribute to the injury itself. Not despite it. Because of it.
>
I'm not talking about acceptance, which is different. I'm talking about people who describe building things, contributing to communities, doing creative work, forming relationships -- that they say they are genuinely uncertain they would have found otherwise.
>
I'm telling you this because it's statistically true, and you deserve to know the complete picture. I'm not telling you this to suggest you should feel that way, or that you will feel that way, or that you should be optimistic right now. You should feel whatever you actually feel.
>
But some people, when they hear this, find it matters to them in a specific way: not as comfort, but as a question. Would you want to be one of the people who finds out what's on the other side of this? That's not a question with a right answer. But it's a question worth sitting with."
What this is not:
What this is:
When a patient asks "what do people do?", the clinician can provide concrete examples:
These are not presented as requirements or expectations. They are presented as examples of the space that opens for some people -- to answer the implied question "what does that even look like?"
Contraindications:
The Executive Care Protocol is designed as a struction -- a structure containing instructions for its own completion. Each layer enables the next:
The communication framework (Section 3) sets the psychological foundation for a patient who will need to engage with a complex rehabilitation protocol for months. Patients who have been given the complete statistical picture -- including the positive-transition phenomenon -- are better positioned to sustain engagement with difficult rehabilitation than patients who have been given only the deficit narrative.
Current system cost (US, high cervical SCI, lifetime):
Executive Care Protocol system cost:
Net savings per patient: $3.1M-$6.0M
At 18,000 new SCI injuries per year in the US, assuming 50% eligible for the full protocol: 9,000 patients × $3.1M average savings = $27.9 billion in annual lifetime-cost savings from a single year's cohort.
This is not a rounding error in healthcare economics. This is a reallocation of the equivalent of a mid-sized hospital system's annual budget, per year, toward patient independence rather than attendant dependency.
Executive care for spinal cord injury is an engineering problem that has been addressed as a social services problem for 80 years. The technology to provide 24/7 independent living infrastructure now exists, and the economics unambiguously favor its deployment over the current human-attendant model.
The communication framework is an ethics problem that has been addressed as an overprotection problem. Patients are capable of handling the complete statistical reality of their injury, including the documented positive-transition phenomenon. Withholding it is paternalistic and harmful.
Both contributions of this paper are straightforward to implement. The barriers are not technical. They are institutional inertia, procurement structures that favor labor over capital, and a clinical culture that conflates "being careful" with "withholding information."
Released under the GPL-3.0. The spec is here. Build the systems. Tell the patients.
Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. This is a design specification and clinical communication framework based on published evidence and does not represent new experimental work.
Conflict of Interest: None declared.
Data Availability: This paper presents no original data. The Positive Transition statistic (15-30%) is derived from published observational literature cited in the references. All design specifications and clinical protocols are provided in full within the text.
License: GPL-3.0 Prior art date: 2026-02-22